JAX donors contribute $100,000 to new COVID-19 models

JAX is fulfilling an urgent need for accurate animal models to test vaccines, neutralizing antibodies and other therapeutics against the SARS-CoV-2 virus to protect the global community against future COVID-19 pandemics. In humans, the virus enters cells by binding to ACE2, a cell surface protein that is slightly different in mice, which as a species, are not naturally susceptible to the disease.  JAX is currently distributing a mouse model called K18-hACE2, donated by its creators Stanley Perlman and Paul McCray, that overcomes this obstacle through the introduction of human ACE2 genes. The resulting transgenic mouse is highly susceptible to SARS-CoV-2 infection. The dissemination of the K18-haACE2 model by JAX is a huge step forward for pre-clinical testing of vaccines and antiviral drugs.

 Next-generation models for COVID-19 research

Thanks in part to recent gifts totaling $100,000 from supporters, JAX scientists will now develop innovative, more accurate mouse models for COVID-19 research that authentically mimic human responses to the viral life cycle. The new models will enable exploration of common and often lethal complications in COVID-19 patients with hypertension, diabetes or cardiovascular conditions. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025